AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dibaglim M 2mg/850mg Tablet

Prescription Icon
Prescription Required

Marketer

Kasdap Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (850mg)

Overview Dibaglim M 2mg/850mg Tablet

Glyciphage M 2mg/850mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by symptoms such as sweating, lightheadedness, headache, and tremors. Learn to recognize and manage these symptoms; consistent meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be minimized. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Dibaglim M 2mg/850mg Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Dibaglim M 2mg/850mg Tablet

Managing Type 2 diabetes

Major Benefits of Dibaglim M 2mg/850mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 2mg/850mg Dibaglim M tablet whole; do not break, crush, or chew it. Administer this medication with a meal.

Common Side effects of Dibaglim M 2mg/850mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Dibaglim M 2mg/850mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Dibaglim M 2mg/850mg Tablet should be administered with a meal.

How Dibaglim M 2mg/850mg Tablet works:

Dibaglim M 2mg/850mg tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Dibaglim M 2mg/850mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dibaglim M 2mg/850mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated for patients using Dibaglim M 2mg/850mg tablets due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Caution is advised when prescribing Dibaglim M 2mg/850mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Dibaglim M 2mg/850mg tablets. Physician consultation is recommended. Regular kidney function assessments are prudent during treatment with this medication.

LiverLiverCAUTION

Patients with liver impairment should use Dibaglim M 2mg/850mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation with a low dose is typical; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Dibaglim M 2mg/850mg Tablet :

Should you forget a dose of Dibaglim M 2mg/850mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dibaglim M 2mg/850mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dibaglim M 2mg/850mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Dibaglim M 2mg/850mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Dibaglim M and seek immediate medical attention.
Dibaglim M 2mg/850mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for treating type 1 DM.
Dibaglim M 2mg/850mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Dibaglim M 2mg/850mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Dibaglim M 2mg/850mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Dibaglim M 2mg/850mg tablets with alcohol is unsafe. Alcohol can worsen the drug's effects, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Dibaglim M 2mg/850mg Tabl...
82
MRP 100
18% off